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ABSTRACT 
 Laboratory testing is necessary when it contributes to the overall clinical management of 
the patient.  Redundant testing, however, is often unnecessary and expensive and contributes to 
overall reductions in healthcare system efficiency.  The purpose of this study is two-fold.  First, 
to evaluate the frequency of ordering duplicate laboratory tests in hospitalized patients and the 
costs associated with this practice.  Second, it was designed to determine if the use of a 
computerized alert or prompt will reduce the total number of unnecessarily duplicated Acute 
Hepatitis Profile (AHP) laboratory tests.   
This two-phase study took place in an inpatient facility that was part of a large tertiary 
care hospital system in Florida.  A retrospective descriptive design was used during Phase 1 was 
to evaluate six laboratory tests and the frequency of ordering duplicate laboratory tests in 
hospitalized patients and to determine the associated costs of this practice for a 12-month time 
period in 2010.  A test was considered a duplicate or an unnecessarily repeated test if it followed 
a previous test of the same type during the patient’s length of stay in the hospital and one in 
which any change in their values likely would not be clinically significant.   
A quasi-experimental pre- and post-test design was used during phase 2 was to determine 
the proportion of duplication of the AHP test before and after the implementation of a 
computerized alert intervention implemented as part of a system quality improvement process on 
January 5th, 2011.  Data were compared for two 3-month time periods, pre- and post-alert 
implementation.   The AHP test was considered redundant if it followed a previous test of the 
same type within 15 days of the initial test being final and present in the medical record.   
 In phase 1, including each of the six tests examined, there were a total amount of 53, 351 
test ordered, with 10, 375 (19.4%) of these cancelled.  Out of the total amount of result final tests 
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(n = 42,976), including each of the six tests examined, 4.6-8.7% were redundant.  Results of the 
proportion of duplication of the six selected tests are as follows:  AHP 196/2514 (7.8%), 
Antinuclear Antibody (ANA) 120/2594 (4.6%), B12/Folate level 396/5874 (6.7%), Thyroid 
Stimulating Hormone (TSH) 1893/21595 (8.7%), Ferritin 384/5171 (7.4%), and Iron/Total iron 
binding capacity (TIBC) 316/5155 (6.1%).  The overall associated yearly cost of redundant 
testing of these six selected tests was an estimated $419, 218.  The largest proportion of 
redundant tests was the Thyroid Stimulating Hormone level, costing a yearly estimated $300, 
987.   
 In Phase 2, prior to introduction of the alert, 674 AHP tests were performed.  Of these, 53 
(7.9%) were redundant.   During the intervention period, 692 AHP tests were performed, of these 
18 (2.6%) were redundant.  The implementation of the computerized alert was shown to 
significantly reduce the proportion of AHP tests (Chi-Square: χ2 = df 1, p ≤ 0.001).  The 
differences in the associated costs of duplicated AHP were $5238 dollars in 2010 as compared to 
$1746 in 2011 post-alert and these differences were significant (Mann Whitney U, Z = -4.04, p ≤ 
0.001).  
 Although the proportions of unnecessarily repeated diagnostic tests that were observed 
during Phase 1 of this study were small, the associated costs could adversely affect hospital 
revenue and overall healthcare efficiency.  The implementation of the AHP computerized alert 
demonstrated a drop in the proportion of redundant AHP tests and subsequent associated cost 
savings.  It is necessary to perform further research to evaluate computerized alerts on other tests 
with evidence-based test-specific time intervals, and to determine if such reductions post-
implementation of AHP alerts are sustained over time.   
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CHAPTER 1: THE PROBLEM 
Significance of the Unnecessary Duplication of Tests 
Rising healthcare costs are no longer sustainable in the current healthcare system.  
Reducing these costs has become a major concern of the U. S. government and healthcare policy 
in this century (DesRoches et al., 2010).  One major component of these costs is the wide range 
and overwhelming number of diagnostic tests available (Jackson, 2007).  The Medicare 
expenditure on laboratory testing was $6.6 billion in 2005 alone. The U.S. healthcare system 
faces urgent challenges to not only improve the quality and safety of care but to also manage 
rising costs (Jha, Chan, Ridgway, Franz, and Bates, 2009).  These laboratories related costs are 
only necessary if they permit accurate diagnosis to be established, proper treatment to be 
initiated and monitored, accurate prognosis to be made, and reductions in patients’ length of 
stays in the hospital (Kwok & Jones, 2004; Walraven & Naylor, 1998).   
While healthcare expenditure per capita in the U.S. is greater than twice that of other 
industrialized countries, the U.S. ranks relatively low on important indicators of the population 
health status and quality of healthcare.  Inefficiencies such as prevalent regional practice 
variations and duplicate tests plague the already burdened healthcare system (Wang et al., 2002; 
National Quality Forum (NQF), 2009; Wennberg, 2002). 
Health care providers are pressed to make an accurate diagnosis and rely on the use of 
laboratory tests or imaging studies in the process of patient management.  However, duplication 
of many of these tests is often unnecessary for the clinical management of patients (Miyakis, 
Karamanof, Liontos, & Mountokalakis, 2006; Nies et al., 2010).  Laboratory testing of 
hospitalized patients can at times be redundant when multiple providers order the same or similar 
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tests on the same patient, contributing needlessly to the total health care system costs (Bates et 
al., 1998; Kwok & Jones, 2005; Walraven & Naylor, 1996).   
In 2009, Jha, et al. performed a comprehensive literature review to identify the rates of 
unnecessary laboratory and radiology tests in U.S. hospitals and associated costs.  They 
concluded eliminating unnecessary laboratory and radiology testing would have saved an 
additional 8 Billion health care dollars in 2004.   
Adverse Effects of Unnecessary Duplication of Laboratory Testing 
Performing redundant tests could have adverse effects for the patient.  For example, 
unnecessary duplicate testing can lead to patient discomfort or sleep disturbance from repeat 
blood draws, risk of false positive results that could induce fear, anxiety, or further unnecessary 
testing in patients, and delayed treatment or length of stay if prior results were not checked and a 
repeat test was ordered (Bates et al., 1999; Jackson, 2007; Kwok & Jones, 2004; Miyakis et al., 
2006; Walraven & Naylor, 1998).   
Nearly all of the clinical and financial impact of a laboratory tests is determined by how 
the test result changes patient management (Jackson, 2007).  Besides increasing healthcare cost, 
frequent unnecessary blood work could potentially reduce the patient’s hemoglobin and 
circulating blood volume, at the same time contributing little to the patient’s clinical 
management (Bates et al., 1998; Beland, D’Angelo, & Vinci, 2003, Jackson, 2007; Kumwilaisak 
et al, 2008). 
Causes of Unnecessary Duplication of Laboratory Testing 
 There are at least five causes for unnecessary duplication of laboratory tests.  First, 
unnecessary testing can occur as a result of false-positive test results and can trigger potentially 
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expensive and dangerous diagnostic evaluations and therapies.  It is particularly concerning 
when a redundant test gives a false-positive result and leads to a lengthy succession of additional 
tests to clarify the result.  This phenomenon has been referred to as the “Ulysses syndrome” and 
is similar to mythological Ulysses who fought in the Trojan War and then decided to come 
home.  During his long trip home he experienced a series of needless and often dangerous 
adventures.  This syndrome refers to the physical and mental changes that occur in patients who, 
though healthy at outset, make a long journey of repeat tests and investigations as a result of a 
false-positive test result.  Thus, these mental and physical changes are a result of the 
investigations themselves and not the therapy  (Jackson, 2007; Rang, 1972). 
Second, computerized physician order entry (CPOE) systems lead to repetitive testing, 
chiefly when the flow of questions or items to be completed do not mirror the routine behavior of 
a clinician (i.e. viewing the results on the monitor verses a summation of laboratory tests printed 
in the chart).  For example, clinicians may order a test for a patient and not recognize that the 
same test has recently been ordered, despite the results of the latest test being saved, resulting in 
a redundant test (Nies et al., 2010).  Fortunately, embedded in the CPOE system is an 
opportunity to improve processes of care that would reduce unnecessary duplication of 
laboratory tests (Jackson, 2007).   
Moreover, some CPOEs have been designed with alerts indicating a test was recently 
performed. However, clinicians often bypass these alerts.  Clinicians can quickly become 
annoyed when the amount of nuisance alerts is deemed too high in relationship to the number of 
valuable alerts, leading to an occurrence called alert fatigue.  The term nuisance alert refers to a 
computerized decisional support system (CDSS) alert that offers modest perceived assistance to 
the clinician at the time of the alert.  These nuisance alerts lead to alert fatigue when clinicians 
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either subconsciously or consciously start bypassing CDSS alerts, with no consideration to their 
importance, permitting clinically significant alerts to be overlooked (Chaffee, 2010).   
 Third, clinician naïveté or lack of knowledge about the proper use of tests, failure to 
confirm earlier results, test ordering customs that are not easily changed, or fear of errors of 
omission and lawsuits (Bates et al, 1998; Kwok & Jones, 2004; Miyakis et al., 2006; Neilson et 
al., 2004) are additional reasons for unnecessary test ordering and duplication.  Fourth, the use of 
protocols or guidelines, inadequate educational feedback, and clinician’s lack of awareness of the 
cost of examinations have been linked as causes for laboratory overutilization (Miyakis, et al., 
2006). Fifth, patient preferences may cause redundant testing when patients actively ask for tests 
and attach greater significance to the test results than is warranted (Kwok & Jones, 2004; Neilson 
et al., 2004). 
Policy Initiatives 
Computerized systems designed for order entry and electronic medical records (EMR) 
represent two of the most highly recommended advances in healthcare.  These systems provide 
opportunities to improve practice by conveying prompts to clinicians at the point of care.  These 
prompts range from straightforward prescribing alerts to more refined support for decision-
making (Shojania et al., 2010).  As would be expected with any other health care innovation, 
CDSSs ought to be scrupulously assessed to ascertain the effects in clinical practice. 
Successions of major policy initiatives, started during the George W. Bush 
administration, concluded in the endorsement of the Health Information Technology Economic 
and Clinical Health (HITECH) Act as a component of the American Recovery and Reinvestment 
Act (ARRA) of 2009 (DesRoches, et al. 2010).  ARRA has offered a projected $20 billion in 
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direct grants and financial incentives to support health care clinicians’ adoption and meaningful 
utilization of EMRs.  ARRA established a requirement that institutions are obligated to exhibit 
“meaningful use” of their Health Information Technology (HIT) system before they can receive 
federal funds to help finance it.  There is regulatory language comprised of twenty-five different 
measures of meaningful use that has now been proposed by the federal government.  Measures of 
meaningful use include such areas as care coordination, privacy and security, quality and 
efficiency, and safe practices (DesRoches, et al. 2010).   
Gever (2010) reported the long-term investment in a HIT system has paid off for the 
Veterans Administration (VA).  The major benefits seen from the use of the HIT system in the 
VA was the deterrence of adverse drug events, trailed by the elimination of medical errors and 
redundancies such as duplicate laboratory tests.  Their HIT system is estimated to save more than 
$500 million in net annual benefits from 2001 to 2007.  
Yet, while there are those who perceive that CDSSs improve effectiveness and reduce 
healthcare costs, the current supporting evidence is limited.  A literature review performed by 
Garg et al. (2005) included controlled trials assessing the effects of CDSSs to identify study 
characteristics predicting the benefit of such systems.  Their findings suggest while some of the 
included studies evaluated costs when outcomes were improved, the cost-effectiveness of these 
systems still remains unknown.   
 Performance measurement is critical to the transformation of the healthcare system 
(NQF, 2009).  There is increasing concern in the area of HIT and its effect on the health care 
system due to technological advances, greater access to computer systems in clinical practice, 
and rising concerns about the process and quality of health care.  These concerns have prompted 
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the need for the assessment and evaluation of the CPOE and CDSSs systems particularly in how 
they affect patient outcomes, cost, and subsequent quality of healthcare (Garg et al., 2005).  
Significance of the Study for Advance Practice Nursing 
The Institute of Medicine’s (IOM) Crossing the Quality Chasm describes six dimensions 
of quality and aims for quality improvement that can be translated into measurable outcomes and 
goals.  One of the aims is efficient care and refers to cost effective care and services and 
reduction and removal of waste from the system.  Efficient care could be measured by evaluating 
the costs of care by organization, provider, community, or patient (Ransom, Joshi, Nash, & 
Ransom, 2008).    
Part of the role of an advanced practice nurse (APN) leader is to help the organization 
keep up with and ahead of the changes that will help the organization thrive in its own 
marketplace.  An effective technique of APNs is to help organizations find efficient, cost 
effective ways of doing business (Porter-O’-Grady & Malloch, 2007). 
Even though economists generally separate the concepts of efficiency and quality, doing 
so in respect to healthcare may not be easy or meaningful.  Since inefficient care utilizes more 
resources than are necessary, it is wasteful care.  Thus, care that involves waste is deficient—and 
therefore lower quality and can be harmful either directly or indirectly by displacing more of the 
resources for useful care (Ransom et al., 2008). 
While it is estimated the direct cost of laboratory testing accounts for less than 5% of the 
total health care costs, laboratory results drive 60% to 70% of major health care decisions, 
including admissions, discharges, and/or initiation of therapies.  APNs and health care 
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organizations have an obligation to patients to actively manage costs by ensuring the appropriate 
services are delivered at the appropriate time (Jackson, 2007).   
There is limited availability of information about the incidence and prevention of 
unnecessary duplicated tests.  Since performance measurement is essential for system 
transformation, research is needed to determine the incidence and associated costs of 
unnecessary duplication of laboratory tests.  Certain laboratory tests may be duplicated more 
than others.  In fact, clinical practice experiences identified a particular set of tests that seemed to 
be frequently and unnecessarily duplicated (see Table 1).  These clinical experiences were 
validated by a preliminary inspection of data provided by the information technology (IT) report 
writer for the hospital laboratory system at the proposed study site.  This motivated the conduct 
of the study described here.  In addition, a particular test, the Acute Hepatitis Profile (AHP) was 
selected for additional analysis for two reasons.  First, the time when the result of the AHP test 
was likely to change is very clear in the literature and allowed for an evidence-based time- 
specific interval to be determined for this test (Porter et al., 2007).  Second, the AHP test 
computerized alert was initiated at the study site, creating a unique opportunity to evaluate 
whether the alert reduced unnecessary duplication of the AHP test.  Results from this study may 
assist APNs in determining if institutional processes need to be evaluated or computerized alerts 
should be implemented in their institution to improve quality and efficiency of patient care.   
Purpose of this Study 
 This study has two phases.  The purpose of phase one is to evaluate the frequency of 
ordering duplicate laboratory tests in hospitalized patients over a 12-month period and the costs 
associated with this practice.  The purpose of phase two is to determine if the use of a 
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computerized alert or prompt will reduce the total number of unnecessarily duplicated Acute 
Hepatitis Profile (AHP) laboratory tests. 
Research Questions 
Phase 1 
1a. In this sample of hospitalized patients, what was the prevalence of duplication 
of the selected laboratory tests (Table 1) over twelve months? 
1b. What were the costs associated with duplication of these laboratory tests? 
 
Table 1: Selected Tests and Unit Costs. 
Test 2011 Unit Costs 
Acute Hepatitis Profile (AHP) $97.00 
Antinuclear antibodies (ANA) $201.00 
B12/Folate level $26.25  
Thyroid Stimulating Hormone (TSH) $159.00 
Ferritin $129.00 
Iron/Total Iron Binding Capacity (TIBC) $48.00 
Note.  M. Nowells (personal communication, January 18, 2011). 
Phase 2 
2a. Did the use of a computerized alert or prompt reduce the total proportion of 
unnecessarily duplicated AHP tests within a three-month period? 
2b. What were the differences in the costs of duplicated AHP laboratory tests 
between the pre- and post intervention time periods?  
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2c. Describe and compare patient, test, and system factors (Table 2) pre- and post-
implementation of the AHP computerized alert for patients with duplicated 
AHP tests. 
2d. Among all patients in the pre- and post-alert study periods, what patient, test, 
and system factors predicted duplication of the AHP test within a 15 day 
period?  
 
Table 2: Patient, Test, and System Factors. 
Age 
Gender  
Ethnicity 
Number of specialists on case associated with duplicate order 
Length of hospital stay 
Mortality 
Initial tests normal or abnormal 
Order status (routine or stat) 
Test duplicated more than one time 
Month test requested 
Presence or absence of computerized alert 
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Research Assumptions 
 The assumptions of this study include the following: 
1. All laboratory tests in the medical record were ordered by the clinician and do not reflect 
a CPOE system error. 
2. Any three-month period of records is representative of test ordering behavior observed 
during the other nine months of the year. 
Definitions of Terms 
Conceptual Definitions of Terms 
The following terms are defined for this study: 
1. An unnecessarily repeated or duplicated test.  An unnecessarily repeated test is defined 
as one that follows a previous test of the same type during the patient’s length of stay in 
the hospital and one in which any change in the test result is unlikely to be clinically 
significant.  This includes a redundant test that could be eliminated with little loss of 
information.  Though there are no customary definitions for categorizing a test as 
redundant, this word often refers to those ordered tests that would be cancelled by 
clinicians if they were made aware of prior results of that test (Bates et al., 1998; Bates et 
al., 1999; Jha et al., 2009; Weydert, Nobbs, Feld, & Kemp, 2005).  For the purposes of 
this study, the phrase unnecessarily repeated test is used interchangeably with a duplicate 
or redundant test. 
2. Clinical provider order entry (CPOE) systems.  CPOE systems are computer-assisted 
information systems that allow clinicians to write orders, including prescribing 
medications and treatments (Schedlbauer et al., 2009).   
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3. Computerized decision support systems (CDSS).  CDSS systems are connected with the 
CPOE to offer support for clinical decision-making by incorporating clinical and patient 
data (Garg et al., 2005; Schedlbauer et al., 2009). 
4. Computerized alert or prompt.  A computerized prompt or alert, generally speaking, is a 
message that pops up on a computer screen to convey information to the clinician 
regarding important information about the patient and the rationale for the alert. Usually, 
it has an “Ok” button to click to indicate that the user has read the vital message and 
would like to continue (Payne, 2000; Weiss & Walter, 1996).  For the purposes of this 
study, the terms computerized alert or prompt are used interchangeably.   
5. Near misses are defined as tests that were ordered but later canceled by the ordering 
clinician, laboratory system, or nurse. 
Operational Definitions of Terms 
The following terms are defined for this study:  
1. An unnecessarily repeated test.  During Phase 1, an unnecessary repeated test was 
identified if the test was performed earlier during that same hospitalization and an 
actual result was final and present in the EMR for the same patient for the same test 
(e.g. the test had not been cancelled in any way or discontinued prior to the final 
results) and any change in their values likely would not be clinically significant.  
During Phase 2, an unnecessarily repeated AHP test was identified when the AHP test 
was performed within 15 days of an actual result being final and present in the EMR 
for the same patient. Clinical evidence indicates the results of an AHP test are not 
likely to change over a 15-day period (Porter et al., 2007). 
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2. Cost per event of repeated unnecessary test.  Only the 2011 direct hospital charges 
for each selected test were evaluated and costs were held constant during both phases 
of the study period (i. e. January 6th, 2010 to April 6th, 2011.  During Phase 1, the 
number of unnecessarily repeated tests was multiplied by the unit charge for the tests 
to give a total annual cost of unnecessarily duplicated tests in each test category 
(Table 1).  During Phase 2, for both periods of data collection, pre- and post-
intervention, the number of unnecessarily duplicated tests over a total of three 
months’ time was multiplied by the hospital charge for each test duplicated.  Indirect 
costs, such as staff wages, supply costs, or cost of adverse events were not included in 
this calculation.   
3. Near misses were identified by any test that cancelled or discontinued after the 
original order was placed in the EMR for the same patient and for the same test.   
Summary 
 The intention of the healthcare delivery system is to maximize health, decrease the 
overall burden of illness, and to increase the value of individual and community resources 
allocated to healthcare (NQF, 2009).  Laboratory testing of hospitalized patients can occasionally 
be superfluous particularly duplicated testing (Nies et al., 2010).  Duplicate testing lowers quality 
of our healthcare system because it uses more resources than necessary (Ransom et al., 2008).   
 A descriptive retrospective review of patient medical records for 2010 was conducted 
during phase 1.  During Phase 2, data regarding the number of AHP tests ordered and duplicated 
were compared for a 3-month period pre- and post-implementation of a computerized alert 
intervention which was introduced to reduce unnecessary duplication of this particular diagnostic 
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test.  The aims of this two-phase study were (1) evaluate the frequency of ordering duplicate 
laboratory tests in hospitalized patients and the costs associated with this practice; and (2) 
determine if the use of a computerized alert or prompt would reduce the total number of 
unnecessarily duplicated AHP laboratory tests. 
 This chapter discussed the background and significance of the problem of unnecessarily 
duplication of laboratory tests.  The research purpose, research questions, research assumptions, 
and conceptual definitions of terms were described.  The significance of this study for advance 
practice nursing was described.  In the next chapter, a synthesis of the literature and research 
evidence will be presented. 
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CHAPTER 2: SYNTHESIS OF THE RESEARCH EVIDENCE 
 The purpose of this chapter is to synthesize relevant research related to the problem of 
unnecessary duplication of laboratory tests.  First, this chapter discusses the quality, efficiency, 
and costs associated with unnecessary duplication of laboratory tests.  Second, this chapter 
discusses administrative interventions that reduce unnecessary duplication of laboratory testing.  
Third, this section discusses relevant literature on test ordering behaviors, and test stability and 
timing of unnecessary duplication of the acute hepatitis profile laboratory tests.  Fourth, this 
section discusses a relevant framework to measure efficiency and how it relates to the current 
study. 
Cost, Quality, and Efficiency of Unnecessary Duplication of Laboratory Tests 
 The U.S. health care system faces several challenges including the critical requirement to 
improve safety, quality, and efficiency of health care, control rising costs, and increase access to 
care.  Several studies have been done to evaluate cost, quality, and efficiency of laboratory 
utilization with emphasis on unnecessary duplication of laboratory tests (Jha et al., 2009; 
Walraven & Raymond, 2003).  
Authors Jha, et al. (2009) used literature based data to estimate the cost of adverse events 
and redundant tests to provide evidence that addressing these situations could generate costs 
savings while improving quality of patient care.  These authors performed a literature review to 
provide estimates of the incidence, preventability, and marginal additional costs of adverse 
events and then reviewed the National Inpatient Sample data to estimate the number of patients 
at risk for preventable adverse events or redundant testing.  Their results suggested eliminating 
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redundant laboratory and radiology tests would have saved and additional $8.2 billion in 2004 or 
an additional 2.7% of total inpatient costs.   
 These results were even more apparent in teaching hospitals, which represent only 10% 
of all hospitals but 20% of all hospitalized patients, where eliminating preventable events and 
redundant tests could save more than $11 billion or 45% of the total costs savings for the entire 
nation.  Furthermore, even facilities with less than 100 beds could collectively save $1.6 billion 
by eliminating avoidable adverse events and $900 million by eliminating unnecessary tests.  
Although these estimates are likely conservative, they can be useful to clinical managers and 
policy makers since these two areas of concern are particularly ripe for preventative 
interventions and measures to improve efficiency (Jha et al., 2009).   
 Another population-based study of redundant laboratory testing was performed by 
Walraven and Raymond (2003) to determine the prevalence of, and associated costs with, 
repetition of eight common laboratory tests, including ferritin, one of the tests investigated in this 
study.  Walraven and Raymond examined population-based clinical databases in Canada for the 
laboratory tests in adults, both inpatient and outpatients, done for one year.   The results of their 
study found the percentage of adult patients having one or more tests increased with age, with 
nearly 75% of those over age 65 having at least one of the study tests.  Duplicate testing within 
one month represented 30% of all utilization (109 repeat tests per 100 people per year).  
Duplication of tests was more common in hospitalized patients, was concentrated to a limited 
number of patients, and varied considerably among tests.   
 Further evidence reflecting the inefficiency of unnecessarily repeating laboratory tests 
was provided by Kwok & Jones (2004) who performed an audit of a governmental tertiary 
hospital laboratory in Hong Kong to determine the number of and associated cost of eight tests 
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that were repeated over a 12-month period.  The tests examined were common rheumatology 
measurements, autoantibodies, and tumor markers.  In this study, the authors found repeat tests 
within 12 weeks of a prior request comprised 16.78% of the total laboratory workload.  
Furthermore, the total cost associated with unnecessary duplication was calculated to be $132, 
151.   
The costs of unnecessary duplication of laboratory tests have been demonstrated in the 
literature to be considerable (Bates et al., 1998; Jha et al., 2009; Kwok & Jones, 2004; Walraven 
& Raymond, 2003). These findings suggest the need for administrative efforts to address the 
issue of unnecessary duplication of laboratory tests and improve resource utilization of health 
care dollars (Jha et al., 2009).  
Administrative Efforts to Reduce Unnecessary Laboratory Testing 
 Several studies have been done evaluating educational interventions, utilization 
management interventions, and models for quality improvement to reduce unnecessary 
laboratory utilization in the hospital setting (Beland, D’Angelo, & Vinci, 2003; Calderon-
Margalit, Mor-Yosef, Mayer, Adler, Shapira, 2005; Nielson et al., 2004; Wang et al., 2002).  In 
an attempt to control healthcare costs and as a part of the preliminary process in creating critical 
paths, nurses in the neurosurgical intensive care unit (NSICU) in Hartford Hospital in 
Connecticut developed a quality improvement process using the IDEA model to reduce 
frequencies of unordered and unnecessary laboratory tests (Beland et al., 2003). 
 The IDEA model is a model for quality improvement and the acronym stands for the 
following steps used in the process: 
• Identify an opportunity or problem for improvement. 
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• Determine all root causes. 
• Establish the plan for action. 
• Act on the established plan. 
Authors collected data on a sample of ten NSICU patients and found that 14.2% of the laboratory 
tests on their first group were unordered and total charges for these tests were $5, 742.34 (Beland 
et al., 2003).   
Throughout their quality improvement process, they continued to collaborate with 
various departments associated with the NSICU and develop blood work guidelines to address 
common reasons unnecessary blood work was sent.  Their initial follow up data showed a 
reduction in the amount of unnecessary or unordered tests being sent by nurses; however, further 
audits again showed an increase in unordered blood work during certain shifts and by certain 
nurses.  These authors admit this is continual quality improvement process and they include 
future plans for auditing and addressing this problem in their NSICU (Beland et al., 2003). 
Calderon-Margalit et al. (2005) conducted a similar administrative quality improvement 
intervention to improve the appropriateness of testing behavior in hospitalized patients and to 
reduce the total number of laboratory tests completed.  Their administrative intervention 
involved restricting available emergency laboratory tests as well as the frequency of repeated 
laboratory test orders.  Incorporated in the intervention were educational strategies to increase 
compliance by all staff members and a presentation on the problem and its consequences.  
Furthermore, a presentation on the new policy and feedback of the intervention’s results were 
reviewed with senior medical staff.  
These authors reported an overall 19% (95% CI: 18.8-19.2%) reduction in laboratory 
tests observed during the first year after the interventions.  Furthermore, the 30-day readmission 
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rates did not differ significantly in the year after the intervention as compared to the year prior to 
the intervention.  However, they did note that the census increase by 3.5% in the year after the 
intervention.  As per the cost estimates of the observed clinical biochemistry tests, the reduction 
in volume of tests seen after the intervention was associated with an approximate cost savings of 
$247, 000.  Even on tests where no intervention was applied (i.e. hematology tests) there was a 
small reduction in ordering practices likely explained by the Hawthorne effect related to the 
spread out effect of the intervention that restricted other tests (Calderon-Margalit et al., 2005).    
Wang, et al. (2002) described a utilization management intervention performed in the 
setting of the coronary care unit to reduce unnecessary testing, including radiographic and 
laboratory testing.  Using evidence-based recommendations, a multidisciplinary team developed 
practice guidelines for routine laboratory and chest radiographic test ordering.  When possible, 
they incorporated expert opinion.  The guidelines were then disseminated to house staff and 
nurses and incorporated into the computer admission order sets for the coronary care unit in a 
large teaching hospital.   
Data were collected for a three-month intervention period and compared to data during 
the same three months of the prior year and compared to the same hospital’s medical intensive 
care unit as control data.  Results during the intervention period suggested significant reductions 
in utilization of all chemistry tests (from 7% to 40% depending on the test); however, reductions 
in ordering arterial blood gas tests, chest radiographs, and complete blood counts were not 
significantly reduced.  Although, after controlling for trends in the control data the reductions in 
chest radiograph (P < .001) and arterial blood gas tests (P = .04) became significant (Wang, et 
al., 2002).   
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The utilization management intervention was not associated with measureable changes in 
patient outcomes such as length of stay, hospital mortality, readmission to the intensive care unit 
or hospital, or days of ventilator support.  Despite the intervention, the total number of laboratory 
tests in this setting remained higher than would be predicted on the basis of the established 
guidelines.  While part of the excess may have been clinically appropriate, these figures suggest 
a call for further reductions in utilization and the need for further research to determine whether 
initial reductions could be maintained over longer periods (Wang et al., 2002).   
In response to an increase in the use of expensive or duplicate testing, the Vanderbilt 
University Medical Center, Nashville, Tennessee, employed a resource utilization committee 
(RUC) to reduce variability in laboratory testing, imaging, and formulary use without restricting 
access to clinically indicated testing.  The RUC initially identified specific patterns of 
unnecessary resource utilization in the hospital and then devised a plan using the CPOE system 
to reduce redundant testing (Neilson et al., 2004). 
The first intervention the RUC implemented was a computerized prompt that appeared 
daily and asked clinicians whether they wanted to discontinue tests scheduled beyond 72 hours.  
The RUC then evaluated the results of the first intervention and subsequently did a second 
intervention to further constrain testing options by unbundling the serum metabolic panel tests 
into single tests and by reducing the ease of repeating targeted tests (chest radiography, glucose, 
creatinine, blood urea nitrogen, electrolytes, and electrocardiogram).  During the third 
intervention, the RUC established a graphic display of the test results from the prior week on the 
ordering page for frequently ordered serum chemistry tests to prevent clinicians from claiming 
the previous result was not known (Neilson et al., 2004).   
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Results of the first intervention or voluntary reduction of testing beyond 72 hours 
decreased orders for metabolic panel component tests by 24% (P = .02) and electrocardiograms 
by 57% (P = .006), but not orders for portable chest radiographs.  The second intervention 
produced an additional decrease of 51% for metabolic panel component tests (P < .001) and 16% 
for portable chest radiographs (P = .03).  No further changes were observed in test-ordering 
trends after the third intervention.  Mortality rates, intensive care transfer rates, length of hospital 
stay rates, and readmission rates were unchanged compared to the rates prior to the intervention  
(Neilson et al., 2004).   
Although authors admit other activities were occurring within the hospital at the same 
time period of the intervention and could have influenced test-ordering behavior, peer 
management of a CPOE system by the RUC produced a dramatic and sustained decrease in test-
ordering behavior.  Since payments for hospitalized patients are based on diagnostic-related 
groups or fixed per diem contracts, a decrease of unnecessary testing that sustains quality of care 
would be advantageous for both hospital finances and resource aptitude (Neilson et al., 2004).   
This section of the chapter described administrative efforts designed to reduce 
unnecessary laboratory utilization.  In most cases, attempts to reduce test ordering were 
successful, with some tests being reduced more than others. The most successful administrative 
efforts were those that used computerized alert reminders or evidenced-based guidelines for 
laboratory testing, and/or constrained testing options for clinicians (Calderon-Margalit et al., 
2005; Neilson et al., 2004; Wang, et al., 2002).  Similar to the study by Neilson et al. (2004), 
which found the computerized alert reduced orders for certain testing, this study evaluated a 
computerized alert intervention for reducing redundant AHP tests to offer further evidence 
regarding the usefulness of this intervention.   
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Test Ordering Behaviors Related to Unnecessary Duplication of Laboratory Tests 
 There are several factors reported in the literature that affect clinicians’ test-ordering 
behaviors.  Sood, Sood, and Ghosh (2007) performed a literature review on the topic and 
described both non-modifiable and modifiable factors affecting test-ordering behaviors of 
physicians.  Non-modifiable factors included practice location, practice setting, age and sex of 
the physician, and specialty of the physician.  Modifiable factors include fear of malpractice, 
physician regret (related to prior experience of regret if diagnosis was missed), financial 
incentives, physician experience or knowledge, belief systems, awareness of the cost of testing, 
fear of malpractice, and education and feedback.  The modifiable variables are among the most 
important since a better understanding of these variables can have a considerable impact on test 
ordering and health care costs.   
 By and large, test ordering is a skill that changes with time and is related to several 
complex interacting factors.  The literature review indicates several physician factors that are not 
evidence-based affect test ordering.  Even though non-evidence-based test ordering does not 
always indicate inappropriate test ordering, an exploration of the reasons why physicians deviate 
from evidence-based test ordering could be informative (Sood et al., 2007).   
 Miyakis, et al. (2006) performed a study to identify factors contributing to laboratory 
overutilization in an academic medical department and to assess the effects of an educational 
feedback strategy on inappropriate test-ordering behavior.  Their findings suggested senior 
trainees ordered more laboratory tests, but the percentage of avoidable tests ordered by junior 
trainees was higher.  Furthermore, trainees had a low and disparate level of awareness about the 
cost of common laboratory tests.  Several independent factors were associated with laboratory 
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over-utilization including patient age ≥ 65 years, length of stay > 7 days, and increased case 
difficulty (one that lead to patient death) or inability to determine a diagnosis. 
 The findings of this study suggested nearly 68% of the laboratory tests frequently ordered 
in an academic internal medicine department could have been avoided with no unfavorable 
effects on patient management.  Furthermore, almost two-thirds of the laboratory tests ordered 
beyond the first 24 hours of hospitalization did not appear to have contributed to the diagnosis, 
while only an estimated one-fourth of the tests ordered within the first 24 hours of hospitalization 
seemed to be redundant.  A feedback approach based on the results of the assessment produced a 
major, yet short-lived, reduction of inappropriate test-ordering behavior (Miyakis et al., 2006). 
 Other reasons cited for unnecessary duplication of laboratory tests by clinicians include 
ease of access to the tests, test addiction, clinicians’ inability to manage the fear of uncertainty, 
and the use of protocols and guidelines (Miyakis et al., 2006; Neilson et al., 2004).  Furthermore, 
inadequate educational feedback, “routine” clinical practice, failure to check previous results, 
test-ordering routines that are difficult to change, and lack of experience has been suggested as 
reasons for excessive test ordering (Kwok & Jones, 2004; Miyakis et al., 2006).  Moreover, the 
patients themselves may contribute to unnecessary duplication of laboratory testing since they 
often actively ask for tests and may attach greater value to the results than warranted (Kwok & 
Jones, 2004). 
 The degree of provider specialization also impacts test-ordering behavior, whereas the 
greater the degree of specialization has been associated with more test- ordering and ordering of 
tests earlier in the patient’s illness.  Despite specialists ordering more test than internists, the tests 
they ordered were more likely to be focused tests and more likely to have positive results (Sood 
et al., 2007).   
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 This section discussed specific clinician factors reported in the literature that affect test 
ordering and test duplication.  Understandably, many factors involving the clinicians, patients, 
and the health care environment influence the test-ordering process. Both modifiable factors and 
non-modifiable clinical factors contribute to test ordering and test duplication, as well as certain 
system and patient factors.  It is theorized that modifiable factors are most important since they 
can have a tremendous impact on test ordering and subsequent healthcare costs (Sood, Sood, & 
Gosh, 2007).  Education and feedback is one modifiable factor this study is evaluating by 
examining the effect of a computerized alert intervention.  The alert intervention being evaluated 
in this study reminds the clinician the AHP test has been recently ordered within an evidence-
based test-specific time interval and notifies them of the date of the prior test.  
Computerized Alert Effects on Test-Ordering and Laboratory Duplication 
 The opportunity to improve patient care using computerized alerts or prompts is one of 
the chief incentives for implementing sophisticated electronic health records.  A landmark study 
was performed by Bates, et al. (1999) to determine the impact of a computerized reminder or 
alert on the reduction of redundant laboratory tests.  This prospective randomized controlled trial 
included all inpatients in a large teaching hospital during a 15 week time period.  The 
intervention involved specific tests with test-specific time intervals and a computerized reminder 
indicating the tests ordered was within the test-specific time period, the result was pending, or 
the result was given if available.   
 During the study period, there were 939 redundant laboratory tests ordered.  Of these, 
69% of the tests in the intervention group were canceled in response to the computerized 
reminder.  Of the 137 overrides of the computerized reminder, 41% appeared to be clinically 
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indicated.  In the control group, the laboratory performed 51% of the redundant tests ordered.  
On the other hand, in the intervention group the laboratory performed only 27% of the ordered 
redundant tests.  Of all redundant laboratory tests performed, only 44% had an associated 
computer order (tests lacking an associated computer order had been sent to the laboratory in a 
labeled envelope and were ordered by clinicians on paper order forms).  Unfortunately, the 
authors did not specify any reasons for why these tests were done without a computer order. 
(Bates et al, 1999).  This study avoids this problem by choosing as study site at which all 
laboratory tests were ordered in the EMR.  If any test were ordered during a computer downtime, 
the order would later be entered into the EMR, as well as the result, once the system was 
operational. 
 To determine if the cancellation of a test due to the computerized reminder had adverse 
clinical effects, the researchers examined the charts of patients where clinicians had accepted the 
reminders to ascertain whether a canceled test was followed within 3 days by an abnormal test 
result.  Excluding chemistry profiles, of the remaining 225 accepted reminders, 119 (53%) were 
trailed by another tests of the same type within 3 days; 55 (24%) were abnormal.  Yet, only 10 
(4%) of these had not been preceded by a similar abnormal result within 24 hours prior to the 
canceled tests.  Thus, only eight (4%) of these tests offered new information and of these only in 
two cases did the new information lead to a change in the clinical management (Bates et al., 
1999).   
 In their study to evaluate the impact of a Serology-CDSS offering point of care alert 
reminders of previous serology results, Nies, et al. (2010) found the proportion of unnecessarily 
repeated serology tests dropped post implementation of the alert and remained stable.  
Conversely, Shohania, et al. (2010) performed a systematic review of literature to quantify the 
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expected magnitude of improvements in processes of care from computer reminders delivered to 
clinicians during routine charting activities or electronic ordering. Their findings suggest 
computerized reminders typically increased adherence to target processes of care by amounts 
below thresholds for clinically significant improvements.  Unfortunately, these authors made no 
determination on whether these alerts reduced overall costs or resource use, such as hospital 
length of stay.  Although many CDSSs may improve practitioner performance, the effects on 
patient outcomes remain understudied or when studied inconsistent (Garg et al., 2005), providing 
a rationale for this study.    
There are significant gaps in the medical literature concerning the most effective methods 
for displaying alerts and prompts supporting the need to investigate how to present and display 
data at the point of care.  Models about the benefits of EMRs advise significant benefits will be 
realized only with advanced decisional support.  However, minor issues relating to human 
factors can have a considerable impact on the success of specific alerts and prompts and research 
is needed since best practices in this area have not been clearly described (Schedlbauer et al., 
2009).  
DesRoches, et al. (2010) used data from a national survey of EMR adoption among acute 
care facilities to investigate the relationship between the adoption of EMR and key metrics and 
accessible measures of quality and effective use of resources.  Findings suggest weak 
relationships concerning key metrics of hospital quality and effective use of resources, and 
across the large number of metrics examined, the relationships were modest at best but generally 
lacked statistical or clinical significance.  These findings imply a careful examination of the 
EMR is needed including examination of how it is used and how best to capitalize on it’s 
potential in improving quality and effective utilization of resources.  To permit payers and 
 26 
providers to make important decisions about implementing EMRs, there is a need for research 
demonstrating how these systems can cost effectively improve care processes (Walker, 2005). 
This section explains studies describing administrative efforts to reduce unnecessary 
duplication of diagnostic tests. Of the administrative interventions described, most had mixed 
results in regards to reducing laboratory test duplication or overutilization.  The two studies 
focusing on evaluating the computerized alert’s effect on test-ordering and unnecessary 
laboratory duplication demonstrated reductions in unnecessary duplication of laboratory testing 
without adversely affecting patient outcomes (Bates et al., 1999, Nies et al. 2010).  Moreover, 
one study demonstrated a potential costs savings with initiation of the computerized alert (Bates, 
et al., 1999).  When the alert was used in combination with constraining testing options for 
clinicians, the combined effect demonstrated further reductions in laboratory duplication and 
overutilization (Neilson et al., 2004).  This added improvement might be related to the high 
constraint put on the clinician’s behavior, as they could not easily override the alert (Nies, et al., 
2010). 
While studies have looked at the effect of alerts on improvements in processes of care 
(Shojania, et al., 2010) or the adoption of EMRs and their relationship to quality and efficiency 
of care (DesRoches et al., 2010), there is limited research evaluating effectiveness of 
computerized alert interventions and potential costs savings, resource use (i.e. length of stay), 
and reduction of unnecessarily repeated tests.  Research is needed in this area.  Research is also 
needed to evaluate clinician tests ordering practices, because these can ultimately affect the 
success of the alert.  Furthermore, there is a gap in the research evaluating whether computerized 
alerts can sustain improvements in system processes without effecting patient outcomes 
(Shohania et al., 2010; DesRoches et al., 2010). 
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Selected Tests for Evaluation 
 Six tests were selected (Table 1) for evaluation for unnecessary ordering and/or 
duplication.  These six tests were selected because clinical observation suggested these six tests 
were often unnecessarily duplicated in routine practice.  Furthermore, a preliminary analysis of 
the data provided from the IT department report writer at the study site verified that these test 
were frequently duplicated.   
 In the setting for this study, the B12 and folate levels are run together as one test.  
Similarly, the iron and TIBC are run as one test.  No clear guidelines are readily available with 
specific time frames on when to repeat the acute hepatitis serology profile.  However, much is 
known about the incubation times of all strains of viral hepatitis, and this information can be 
used to determine when duplication of an AHP would be redundant.  Preliminary laboratory 
assessment of patients with acute hepatic injury should include an acute hepatitis panel.  IgM 
anti-HAV, the indicative laboratory test of choice for acute hepatitis A virus infection, 
disappears by 4-6 months, while total HAV antibodies endure for life.  IgM anti-HBc and 
HBsAg are the most dependable tests for acute hepatitis B virus infections; IgG (and thus total) 
anti-HBc endure for several years (Dufour et al., 2000). 
Both anti-HCV and HCV RNA can be present in acute and chronic hepatitis C virus 
infections and diagnosis can be presumptively made by negative HAV and HBV markers, recent 
exposure, and a negative anti-HCV at initial presentation with conversion of positive anti-HCV 
within 1-3 months (Dufour et al., 2000).  Incubation periods for all types of viral hepatitis are 
anywhere from 15-180 days (Porter et al., 2007).   
In their study evaluating the effect of a computerized alert on unnecessarily repeated 
serology tests, Nies, et al. (2010) considered an unnecessarily repeated hepatitis serology test 
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was one that occurred within 90 days of the previous result.  Conservatively, for this study, based 
on the incubation periods of all strains of viral hepatitis, if an acute hepatitis profile is repeated 
within a 15-day time interval it was considered unnecessarily duplicated.  In the setting for this 
study, the AHP is ran and charged as one test and includes the following tests:  Hepatitis A (AB) 
IgM, Hepatitis B Core (AB) IgM, Hepatitis B Surface Antigen, and Hepatitis C (AB), IgM. 
Theoretical Framework:  The National Quality Forum (NQF) Measurement Framework 
 The NQF, interdisciplinary, measurement framework provides theoretical justification for 
this study.  The framework specifies how best to evaluate efficiency across patient-focused 
episodes of care (NQF, 2009).  The NQF purports the purpose of the healthcare delivery system 
is to improve health, diminish the burden illness, and make the best use of individual and public 
resources allocated to healthcare. Hence, this study focuses on the improper care of 
unnecessarily duplicative diagnostic testing.  Such testing is clearly not efficient care.  This 
framework identifies cost and resource use and processes of care as key measurement domains 
with respect to assessing quality of care.  Hence, this study estimates the costs associated with 
unnecessarily duplicated diagnostic tests (Table 1), and determines if the implementation of a 
computerized alert reduces unnecessary duplications of the AHP test and reduces associated 
costs of redundant AHP tests. The latter will provide insights into processes of care. 
Summary 
 This chapter described relevant research relevant to the problem of unnecessary 
duplication of laboratory tests, including resource use associated with redundant testing and 
interventions for reducing unnecessary testing.  Furthermore, this chapter described available 
literature on test ordering behaviors and test stability and timing of unnecessary duplication of 
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the acute hepatitis profile laboratory tests.  A theoretical framework for defining and measuring 
quality of care was used to provide justification for this study. 
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CHAPTER 3: METHODS 
First, this section discusses the setting for the study, sample criteria and methods of chart 
selection, and protection of human subjects for phase 1 and Phase 2 of the study.  Second, the 
research design and rationale for the chosen design are discussed.  Third, procedures and data 
analysis for phase 1 and phase 2 of the study are discussed separately.   
Setting for the Study 
This study was performed in two phases.  Both phases of the study took place in a large 
tertiary care organization in central Florida.  This organization has several major medical 
departments including internal medicine, cardiovascular and stroke units, and emergency 
services.  The facility utilizes the Eclipsys® EHR centered on the Sunrise Clinical Manager™.  
The Sunrise Clinical Manager incorporates systems for CPOE and CDSS for clinicians 
(Eclipsys® Retrieved October 2, 2010 from: http://www.eclipsys.com/hospitals-clinical-
solutions-acute--care-ehr.htm).   
Sample Criteria and Methods for Chart Selection 
 The sample criteria and data extraction methods for chart selection were the same for 
both Phase 1 and Phase 2 of the study.  However, the sampling period varied for the two phases.  
Both phases used a purposive sample of all patients admitted to a local tertiary organization, over 
age 18 years of age, who received an order for any of the selected tests (Table 1).  Patients were 
excluded from the analysis if they were discharged from the hospital less than 24 hours after 
their admission.  Furthermore, patients were excluded if their medical record was incomplete or 
did not contain any duplication in ordering of the selected tests.  Incomplete medical records 
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were those records that did not contain information on patient characteristics of age, gender, or 
ethnicity.   
Protection of Human Subjects 
 The Institutional Review Boards (IRBs) approval from the University of Central Florida 
and the local tertiary organization was obtained prior to data collection.  Any amendment in the 
protocol was requested and approved by both of these IRBs prior to data collection. 
Statistical Analysis 
 The statistical analysis for both Phase 1 and Phase 2 data were conducted using PASW® 
Statistics GradPack for MAC® database (version 17.0, SPSS, Chicago, IL, USA).  A description 
of the analyses performed during each phase of the study will be described separately. 
Phase 1 Design 
 A retrospective descriptive design was used for Phase 1 to evaluate the prevalence with 
which selected tests (Table 1) are duplicated.  Data were collected for a twelve-month time 
period in 2010.  This design was chosen to allow for retrospective chart review of the selected 
tests to determine which of these tests were duplicated and to determine which of these tests 
were “near misses.”  Near misses are defined as tests that were ordered but later canceled by the 
ordering clinician, laboratory system, or nurse.   
Phase 1 Procedures 
For each laboratory test (Table 1), a computerized database review of all tests ordered 
and duplicated on inpatients during a twelve-month time period between January 6th, 2010 and 
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December 31st, 2010 was executed.  This was done to determine which of these tests were 
ordered and canceled and which were duplicated during this twelve-month time.  These 
particular diagnostic tests were chosen based on a preliminary analysis of test-ordering patterns 
that showed that they were frequently duplicated.  Additionally, unlike many other laboratory 
tests, duplication of these test do not add significantly to the clinical management of patients 
(Heuston, 2001; Kwok & Jones, 2004; Munoz, Villar, & Garcia-Erce, 2009; Porter et al., 2007; 
Smellie et al., 2005).  Census data during the twelve-month data collection period in 2010 was 
collected to determine if fluctuations in the census contributed to laboratory tests duplication 
rates.   
Data were provided by the tertiary care organization’s Information Technology (IT) 
Department report writer and included the medical record number.  Data were kept on a 
password-protected computer.  Data were coded, the medical record number removed, and the 
original data file destroyed.  Data were coded by assigning each patient a unique identifier 
different from the medical record number and the medical record number was removed from the 
data file prior to analysis in order to preserve confidentiality.  The medical record number and 
code number list was stored separately in a locked file cabinet in a private office at the tertiary 
care facility for patient confidentiality.   
For each selected test (Table 1), the total number of tests ordered and canceled or 
duplicated per total tests ordered was reported.   Data integrity of the electronic database was 
verified by retrieving a random subset of 5 charts from the medical records using the medical 
record number.  Charts were retrieved manually and the duplication of each test was verified and 
compared to the data received from the IT department’s prepared data report.  It also allowed for 
assessment of data quality for Phase 2.  As part of data verification, the demographic 
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characteristics for patients with AHP tests in the first quarter (Q1) in 2010 were compared to 
those in the last 3 quarters (Q1, Q2, Q3) in 2010 combined in order to assess if the 3-month 
sample would be representative of the rest of the year.  There were no significant differences in 
the characteristics between the two periods (p = ≥ 0.05) suggesting that Q1 was comparable to 
the last 3 quarters (Appendix E).  
Phase 1 Statistical Analyses 
 Phase 1 research questions and statistical analysis for each one are outlined below. 
1a. In this sample of hospitalized patients, what was the prevalence of duplication 
of the selected laboratory tests (Table 1) over twelve months? 
Analysis:  Descriptive statistics were used to summarize ordering and duplication of the 
selected tests (Table 1) using proportions.   
1b.  What were the costs associated with duplication of these laboratory tests? 
Analysis:  A cost analysis was performed on the tests (Table 1) for the total number of 
duplicated tests ordered and completed within a twelve-month time period from January 6th, 
2010 to December 31st, 2010.  The annual cost for unnecessary duplication of the tests was 
estimated using the 2011 unit charge for each test.  The total costs associated with unnecessary 
duplicated tests were multiplied by the hospital charge for selected test to obtain the projected 
annual cost associated with unnecessary duplication.  The formula used for calculating total costs 
for one year was annual costs = unit cost for test x number of duplicated tests in one year. 
Phase 2 Design 
For this phase, only the AHP tests were evaluated.  A quasi-experimental pre- and post-
test design was used to determine the difference in proportion of duplication of AHP tests 
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observed for a 3-month period before and a 3-month period after the implementation of a 
computerized alert intervention.  Hereafter, these two periods are referred to as pre-alert and 
post-alert.  This design was selected to allow a field test of the computerized alert to determine if 
the implementation of the alert may reduce the proportion of duplicated AHP tests.  It also 
allowed for assessment of data quality for Phase 2.   
Phase 2 Procedures for Implementation of Computerized Alert 
As part of a hospital wide initiative to reduce laboratory duplication and as part of the 
normal workflow of the laboratory supervisor, a computerized alert for the AHP was created and 
implemented on January 5th, 2011.  The computerized alert produces a pop-up screen on the 
computer and notifies the clinician ordering the AHP test that it is within the test-specific time 
frame.  The alert produces a message stating “incubation periods for all types of viral hepatitis is 
anywhere from 15-180 days.”  The test-specific time frame was set at 15 days prior to entering 
the order for the AHP and for 15 days in the future.  
The alert indicates to the clinician that the test has recently been ordered (within the test-
specific time frame and is either completed and the date, pending, or scheduled to be done in the 
future) and asks clinicians whether or not they want to proceed with ordering the selected test 
(Figure 1).  The alert does not prohibit clinicians from ordering the test if they choose to ignore 
the alert.  The alert was implemented hospital wide to display on the monitor screen from any 
location of entry into the system, including home and other community hospital sites.  
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Figure 1: Computerized Alert. 
 
D. Mohr (personal communication March 18, 2011).  Reprinted with permission. 
 
 
 In an attempt to evaluate this system change already in progress, data were collected 
following initiation of the computerized alert starting on January 6, 2011 and continued over the 
next 3-month period until April 6, 2011.  Data were collected on all patients admitted to the 
hospital who received an order for the AHP to determine the prevalence of unnecessary ordering 
or duplication of the test.  Data were compared to the data for the same three months in 2010 pre-
intervention time period; from January 6th, 2010 through April 6th, 2010, to determine if the 
computerized alert decreased unnecessary duplication.  The data collected included patient, test, 
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and system factors (Table 2) for any AHP test duplicated during both the pre- and post-
intervention time periods.   
Data were provided by the tertiary care organizations IT department report writer and 
included the medical record number, which was coded and removed from the data set prior to 
analysis.  Patient confidentiality was maintained on all data collected as described in Phase 1.   
Data integrity of the electronic database was verified by retrieving a random subset of 5 charts 
from the medical records using the medical record number.  Charts were retrieved manually and 
the duplication of each test was verified and compared to the data received from the IT 
department’s prepared data report. 
Phase 2 Statistical Analyses 
 The statistical analyses for Phase 2 research questions are outlined below. 
2a. Did the use of a computerized alert or prompt reduce the proportion of 
unnecessarily duplicated AHP tests within a three-month period? 
Analysis:  A comparisons of the proportion of duplicated tests in the pre- and post-alert 
periods was conducted using the Z-test for the difference of the proportions. 
2b. What were the differences in the costs of duplicated AHP laboratory tests 
between the pre- and post-intervention time periods?  
Analysis:  The same formula used during Phase 1, for calculating cost of duplication of 
the AHP tests was used in Phase 2, except over the two (pre- and post-alert) 3 month time 
periods.  The formula used to calculating total costs for each quarter was quarterly costs = unit 
cost for AHP test x number of AHP tests duplicated in that quarter.  
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To evaluate whether the computerized alert reduced total costs of duplicated AHP, the 
total costs of duplicated tests ordered and completed during January 6th, 2010 and April 6th, 
2010 prior to the alert intervention was calculated and compared to those unnecessarily 
duplicated during the 3-month post alert intervention from January 6, 2011 and April 6, 2011.  
Comparisons between the pre- and post- intervention costs were conducted using the Z-test for 
the differences. 
2c. Describe and compare patient, test, and system factors (Table 2) pre- and post-
implementation of the AHP computerized alert for patients with duplicated 
AHP tests. 
 Analysis:  Descriptive statistics including mean, median, percentages, and  range were 
used to summarize patient, test, and system factors related to the AHP test being duplicated pre- 
and post-computerized alert intervention.  In addition, a series of univariate analyses (including 
t-test, chi-square, Fisher’s Exact, and Contingency Coefficient, depending on variance, 
distribution, and type of data) were used to compare the factors pre- and post-alert intervention. 
2d. Among all patients in the pre- and post-alert study periods, what patient, test, 
and system factors predicted duplication of the AHP test within a 15 day 
period 
Analysis:  Descriptive statistics including mean, median, percentages, and  range were 
used to summarize patient, test, and system factors in the duplicated and not duplicated 
populations.  In addition, a series of univariate analyses (including t-test, chi-square, Fisher’s 
Exact, and Contingency Coefficient, depending on variance, distribution and type of data) were 
used to compare the factors (Table 2) that were associated with the duplication of the AHP 
during both pre- and post-intervention time periods.  A binary logistic regression was performed 
 38 
to calculate the adjusted odds ratios for each clinical factor (Table 2). The dependent variable 
was whether or not there was duplication of the AHP test (not duplicated = 0 and duplicated =1). 
The independent variables included the patient factors in Table 2.   
The Phase 2 sample size of 1366 provided sufficient power to detect a significant odds 
ratio (OR) with OR > 1.84 or > 0.42 in the analyses addressing question 2d in which the obtained 
proportion of AHP duplication was 5.2%.  This calculation assumes an alpha of .05 and a power 
of .80.  ORs that are smaller in magnitude than these values are not likely to be clinically 
significant.  
Summary 
This chapter described the setting for the study, sample criteria, methods of chart 
selection, and protection of human subjects for both phases of the study.  It also details two 
separate phases of the study, including each phase’s research design and rationale for the chosen 
design, procedures, and data analysis.  The procedure for implementing the computerized alert 
during Phase 2 of the study was discussed.   
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CHAPTER 4: RESULTS AND ANALYSIS OF DATA 
 This study was conducted to evaluate the prevalence of duplicated laboratory testing in 
hospitalized patients and the costs associated with this practice.  In addition, this study was 
performed to evaluate the use of a computerized alert intervention, alerting the clinician of an 
existing test, to determine if its implementation would reduce the total number of duplicated 
AHP laboratory tests.  This section describes the results of the data analysis related to the 
research questions. 
Phase 1  
Research Questions and Results 
1a.   In this sample of hospitalized patients, what was the prevalence of duplication of 
 the selected laboratory tests (Table 1) over twelve months?   
1b.  What were the costs associated with duplication of these laboratory tests? 
Repeat AHP Testing and Yearly Costs of Duplication 
 During the twelve-month study period in 2010, there were a total of 3355 AHP tests 
performed; of these, 768 (22.9%) were cancelled tests.  Out of the 2514 tests with reported final 
results, 196 (7.8%) were duplicated.  The total yearly cost associated with redundant AHP tests 
was $19,012.  Characteristics of duplicated AHP tests are summed up in Table 3. 
Repeat ANA Testing and Yearly Cost of Duplication 
 During the twelve-month study period in 2010, there were a total of 3035 ANA test 
performed; of these 441 (14.5%) were cancelled tests.  These tests were cancelled by the 
laboratory, nurse, ordering clinician, or by patient discharge.  Out of the 2594 tests with reported 
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final results, 120 (4.6%) were redundant.  The yearly cost associated with redundant ANA tests 
was $24, 120.  Characteristics of duplicated ANA tests are summed up in Table 3. 
Repeat B12/Folate Testing and Yearly Cost of Duplication 
 During the twelve-month study period in 2010, there were a total of 7229 B12/Folate 
tests performed; of these 1355 (18.7%) were cancelled tests.  Out of the 5874 tests with reported 
final results, 396 (6.7%) were redundant.  The yearly cost associated with redundant B12/Folate 
tests was $10,395.  Characteristics of duplicated B12/Folate tests are summed up in Table 3. 
Repeat TSH Testing and Yearly Cost of Duplication 
 During the twelve-month study period in 2010, there were a total of 27,475 TSH tests 
performed; of these 5880 (21.4%) were cancelled tests.  Out of the 21, 595 tests with reported 
final results, 1893 (8.7%) were redundant.  The total yearly cost associated with redundant TSH 
tests was $300, 987.  Characteristics of duplicated TSH tests are summed up in Table 3. 
Repeat Ferritin Testing and Yearly Costs of Duplication 
 During the twelve-month study period in 2010, there were a total of 6099 Ferritin tests 
performed; of these, 928 (15.2%) were cancelled tests.  Out of the 5171 tests with reported final 
results, 384 (7.4%) were redundant.  The total yearly cost associated with redundant Ferritin tests 
was $49,536.  Characteristics of duplicated Ferritin tests are summed up in Table 3. 
Repeat Iron/TIBC Testing and Yearly Costs of Duplication 
 During the twelve-month study period in 2010, there were a total of 6158 Iron/TIBC tests 
performed; of these, 1003 (16.3%) were cancelled tests.  Out of the 5155 tests with reported final 
 41 
results, 316 (6.1%) were redundant.  The total yearly cost associated with redundant Iron/TIBC 
tests was $15, 168.  Characteristics of duplicated Iron/TIBC tests are summed up in Table 3. 
Summary 
 Including each of the six tests examined, there were a total amount of 53, 351 tests 
ordered, with 10, 375 of these cancelled.  Out of the total amount of tests conducted (n = 
42,976), 4.6-8.7% were redundant, depending on the specific type of test.  The overall associated 
yearly cost of redundant testing for these six selected tests was an estimated $419, 218.  The 
largest proportion of redundant tests was the Thyroid Stimulating Hormone level (n = 1893), 
costing a yearly estimated $300, 987.  These totals are summed up in Table 3. 
 
Table 3: Characteristics of Six Selected Tests.  
Test Total 
Number of 
Tests 
Total 
Cancelled 
Tests 
Total Results 
Final 
Total 
Redundant 
Tests 
Yearly Costs 
AHP 3355 768 
(22.9%) 
2514 196 
(7.8%) 
$19,012 
ANA 3035 441 
(14.5%) 
2594 120 
(4.6%) 
$24,120 
B12/Folate 
Level 
7229 1355 
(18.7%) 
5874 396 
(6.7%) 
$10,395 
TSH 27475 5880 
(21.4%) 
21595 1893 
(8.7%) 
$300,987 
Ferritin 6099 928 
(15.2%) 
5171 384 
(7.4%) 
$49,536 
IRON/TIBC 6158 1003 
(16.3%) 
5155 316 
(6.1%) 
$15,168 
Totals  53, 351  10, 375  
(19.4%) 
42,903 3305 
(7.7%) 
$419,218 
Note.  AHP = Acute Hepatitis Panel; ANA = Antinuclear antibodies; TSH = Thyroid Stimulating Hormone; TIBC = 
Total Iron Binding Capacity. 
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Phase 2 
Research Questions and Results 
2a. Did the use of a computerized alert or prompt reduce the proportion of 
unnecessarily duplicated AHP tests within a three-month period? 
The demographic characteristics for the patients in the Phase 1 and Phase 2 are presented 
in Table 4.  As can be seen from the data in the table, the samples used for Phase 1 and the pre- 
and post-alert periods in Phase 2 were very similar.  The length of stay for Phase 1 and for the 
two periods in Phase 2 (pre and post-alert) ranged from 1 to 208 days.  Additional sample 
demographics are provided in Table 6 and Appendix C.   
 There were a total of 1969 AHP tests performed in this local tertiary care hospital system 
during the combined three-month study period.  Due to missing clinical data and duplication in 
data entry, a total of 1366 patients were available for analysis (Figure 2).  In the pre-alert time 
period in 2010, there were 674 patients with AHP tests ordered and in the post-alert period in 
2011, there were 692 patients with AHP tests ordered.  The proportion of patients with at least 
one duplicated AHP test in the pre-alert period was 53/674 (7.9%), and the proportion of patients 
with at least one duplicated AHP test in the post-alert period was 18/692 (2.6%) (Figure 3).  This 
represents a statistically significantly reduction in the proportion of patients with duplications of 
the AHP test following introduction of the computerized alert (χ2= 19.1, df 1, p = ≤ 0.001).   
Figure 4 illustrates the ordering pattern and percentages of duplicate AHP tests performed each 
month from January to April in the pre- and post-alert time periods. Of those with duplicate AHP 
tests, 2/53 (3.8%) patients in the pre-alert study period and 2/18 (11.1%) in the post-alert period 
had the AHP test duplicated 2 or more times.   
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 Census data was collected during both study periods pre- and post-alert.  The number of 
inpatients in all facilities within this tertiary care hospital system during the pre-alert study 
period in 2010 was 27, 265 patients, as compared to 24, 933 patients during the post-alert study 
period in 2011.  There was a total of 2,332 more inpatients system-wide, distributed among all 
facilities, in 2011 (9.4% increase) as compared to the same time period in 2010. 
 
Table 4: Comparison of the Demographic Characteristics of the Study Populations of those with 
AHP Tests in Phase 1 and Phase 2 of the Study. 
 Patients in 
Phase 1 
N=2514 
Patients in Phase 2 
(pre-alert)a 
N=674 
Patients in Phase 2 
(post-alert) 
N=692 
Age in years (±SD) 
     Range  
53 (±18) 
Range (18-
112) 
54 (±18) 
Range (18-99) 
52 (±18) 
Range (18-93) 
Gender (% female) 1224 (49%) 336 (50%) 321 (46%) 
Race (%) 
     Asian 
     Black 
     Caucasian 
     East Indian 
     Hispanic 
     Other 
 
66 (2.6%) 
649 (25.8%) 
1268 (50.4%) 
28 (1.1%) 
487 (19.4%) 
16 (0.6%) 
 
22 (3.3%) 
162 (24.0%) 
348 (51.6%) 
10 (1.5%) 
127 (18.8%) 
5 (0.7%) 
 
27 (3.9%) 
177 (25.6%) 
353 (51.0%) 
5 (0.7%) 
127 (18.4%) 
3 (0.4%) 
Order Status (%) 
     Routine 
     Stat/Timed 
 
2087 (83.0%) 
427 (17.0%) 
 
555 (82.3%) 
119 (17.7%) 
 
603 (87.1%) 
89 (12.9%) 
Mortality 108 (4.3%) 33 (4.9%) 30 (4.3%) 
Disposition from Hospital 
     Home/Rehab 
     Long-term Care/Death 
 
2114 (84.1%) 
400 (15.9%) 
 
570 (84.6%) 
104 (15.4%) 
 
590 (85.3%) 
102 (14.7%) 
Length of Hospital Stay in 
days (±SD) 
     Range 
 
9.2 (±12.3) 
Range (1-208) 
 
8.9 (±12.3) 
Range (1-117) 
 
8.9 (±12.2) 
Range (1-104) 
a These data are from a subsample of Phase 1 patients admitted during the first 3 months of 2010.  Statistical 
analyses indicate that this 3 month subsample does not differ from the remaining 9 month 2010 subsample with 
respect to the demographic characteristics listed in the table (p > 0.21; see also Appendix C). 
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Figure 2: Phase 2 Results. 
 
Note.  AHP = Acute Hepatitis Profile 
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Figure 3: Comparison of the Proportion (Percent) of Patients with Duplicate AHP Tests 
Performed Before and After the Alert Protocol was Implemented (January to April 2010 versus 
January to April 2011) (Chi-Square; χ2=19.1; df 1; p<0.001). 
 
 
p<0.001 
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Figure 4: Ordering Pattern and Percentage of Duplicate AHP Tests Performed in Each Month 
from January to April in the Pre- and Post-alert Periods. 
 
Note: CI = confidence interval. April data include only 6 days of observations.   
 
2b. What were the differences in the costs of duplicated AHP laboratory tests 
between the pre- and post-intervention time periods?  
 The costs associated with the duplicated AHP tests during the study periods in 2010 and 
2011were $5,141 and $1,746, respectively:  a reduction of $3, 395 over the 3-months after the 
alert was implemented (Mann Whitney U; Z = -4.04; p ≤ 0.001) (Figure 5).   
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Figure 5:  Comparison of the Total Cost of Duplicate AHP tests Performed Before and After the 
Alert Protocol Was Implemented (January to April 2010 versus January to April 2011) (Mann 
Whitney U; Z = -4.04; p ≤ 0.001).  
 
 
2c. Describe and compare patient, test, and system factors (Table 2) pre- and post-
implementation of the AHP computerized alert for patients with duplicated 
AHP tests. 
 In order to assess clinical factors that were not available in the electronic database file 
provided by the IT department report writer, each patient had additional data extracted from their 
individual medical records.  During the three-month pre-alert study period (2010), a total of 53 
patients (7.9%) had a duplicate AHP test performed and during the post-alert study period in 
(2011), 18 patients (2.6%) had a duplicate AHP test performed for a total of 71 patients in the 
analysis. Comparisons of the characteristics of those patients who had duplicate AHP tests 
performed in the periods before and after the alert intervention summarized in Table 5.   
p≤0.001 
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 There were no significant differences in the characteristics of people who experienced a 
duplicate AHP test between the two study periods with regards to age, gender, or ethnicity.  In 
addition, there were no statistically significant differences in order status (routine verses stat), 
mortality, disposition after discharge from hospital, whether the initial test was abnormal, the 
number of specialists on the case, whether the test was repeated more than once, or length of 
hospital stay, with all factors having a p value > 0.05.  There was, however, a significant 
difference between the two groups with respect to the month in which the duplicate test was 
requested (Contingency Coefficient 0.32, p = 0.04).  In the pre-alert period, the number of 
duplicate tests was distributed evenly over 3 months. However, in the post-alert period the 
majority of duplications occurred in the month of January when the alert was first introduced and 
remained low over the subsequent months.  
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Table 5: Comparison of Characteristics of Patients who had Duplicated AHP Tests in Periods 
Before and After Implementation of Computerized Alerta. 
 Patients with 
Duplicates Pre-
Alert 
N=53 
Patients with 
Duplicates Post-
Alert 
N=18 
Statistic and p 
Value 
Age in years (±SD) 56 (±17) 
Range (24-93) 
56 (±18) 
Range (23-89) 
t = 0.04,  
p = 0.90 
Gender (%female) 21 (40%) 9 (50%) χ2= 0.59, df= 1,  
p = 0.58 
Race  
     Asian 
     Black 
     Caucasian 
     East Indian 
     Hispanic 
 
2 (3.8%) 
13 (24.5%) 
25 (47.2%) 
1 (1.9%) 
12 (22.6%) 
 
2 (11.1%) 
3 (16.7%) 
9 (50%) 
1 (5.6%) 
3 (16.7%) 
 
Contingency 
coefficient = 0.09, 
p = 0.44 
Order Status (%) 
     Routine 
     Stat/Timed 
 
41 (77.4%) 
12 (22.6%) 
 
15 (83.3%) 
3 (16.7%) 
 
Fisher’s Exact test:  
p = 0.75 
Mortality 5 (9.4%) 2 (11.1%) Fisher’s Exact test:   
p = 0.99 
Disposition from Hospital 
     Home/Rehab 
     Long-term Care/Death 
 
41 (77.4%) 
12 (22.6%) 
 
11 (61.1%) 
7 (38.9%) 
χ2= 1.81,  
df = 1,  
p = 0.22 
Initial Test was Abnormal 4 (7.5%) 
 
3 (16.7%) Fisher’s Exact test:  
p = 0.36 
Mean number of 
specialists on the case 
3.3 (±2.5) 
Range (0-12) 
3.5 (±3.2) 
Range (1-14) 
t = -0.22,  
p = 0.83 
Test duplicated multiple 
times (>1 duplicate) 
2 (3.8%) 2 (11.1%) Fisher’s Exact test: 
  p = 0.27 
Length of Hospital Stay 
in days (±SD) 
10.8 (±12.8) 
Range (1-79) 
18.0 (±25.9) 
Range (2-105) 
t = -1.14,  
p = 0.27 
Month Test Requested 
     January 
     February 
     March 
     April 
 
13 (24.5%) 
13 (24.5%) 
21 (39.6%) 
6 (11.3%) 
 
11 (61.1%) 
3 (16.7%) 
3 (16.7%) 
1 (5.6%) 
 
Contingency 
coefficient = 0.32, 
p = 0.04 
aApril data includes only 6 days of observations.  N = number; Chi-square = χ2; df = degrees of freedom; t-test = t. 
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2d. Among all patients in the pre- and post-alert study periods, what patient, test, 
and system factors predicted duplication of the AHP test within a 15 day 
period 
 Given the lack of demographic and clinical factor differences between patients with 
duplicated AHP tests during the pre- and post-alert periods, data from the two periods were 
combined.  This resulted in a total of 1366 patients who had a least one AHP test performed.  Of 
these, 71 patients (5.2%) had a duplicated AHP test (with duplication group) and 1265 patients 
(92.6%) had a single test performed (without duplication group). Characteristics of these patients 
groups, with and without duplicate AHP testing, were compared using the clinical data available 
electronically from the hospital database file provided by the IT department report writer.   
Results are summarized in Table 6.   
 There were no significant differences between patients who had duplicate AHP (n = 71) 
tests and those who did not (n = 1265) with regards to patient age, gender, ethnicity, order status 
of test (routine or stat), and length of hospital stay, with all factors having a p value of > 0.05.  
There were, however, significant differences in the month the test was requested (contingency 
coefficient 0.12; p ≤ 0.001).  It is likely that ordering patterns in the duplicated group changed 
once the alert was instituted, resulting in the differences between the groups (Figure 6). 
 There was also a statistically significant difference in mortality between the two groups, with a 
higher mortality in those patients with duplication (9.9%) than those without duplication (4.3%) 
(χ2 = 4.69, df 1, p = 0.04).  There were also statistically significant differences in disposition 
from hospital.  There were a larger proportion of patients with poor outcome/disposition (long-
term care or dying) at 26.8% in the duplication group compared to those without duplication at 
14.4% (χ2 = 7.98, df 1, p = 0.009).  These results are summarized in Table 6. 
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Table 6: Comparison of Characteristics of Patients With and Without Duplicate AHP Tests 
During Both 2010 and 2011 Study Periods Combineda. 
 Patients with 
Duplicate AHP  
 
N=71 
Patients without 
Duplicate AHP 
 
N=1265 
Statistic and 
P-value 
Age in years (±SD) 56 (±17) 
Range (23-93) 
53 (±18) 
Range (18-99) 
t = 1.53, 
p = 0.13 
Gender (%female) 30 (42%) 627 (48%) χ2 = 1.02,  
df = 1, 
p = 0.33 
Race (%) 
     Asian 
     Black 
     Caucasian 
     East Indian 
     Hispanic 
     Other 
 
4 (5.6%) 
16 (22.5%) 
34 (47.9%) 
2 (2.8%) 
15 (21.1%) 
0 
 
45 (3.5%) 
323 (24.9%) 
667 (51.5%) 
13 (1.0%) 
239 (18.5%) 
8 (0.6%) 
 
Contingency 
coefficient = 
0.05, 
p = 0.56 
Order Status (%) 
     Routine 
     Stat/Timed 
 
56 (78.9%) 
15 (21.1%) 
 
1102 (85.1%) 
193 (14.9%) 
χ2 = 2.02,  
df = 1, 
p = 0.17 
 
Mortality 7 (9.9%) 56 (4.3%) χ2 = 4.69,  
df = 1, 
p = 0.04 
Disposition from Hospital 
     Home/Rehab 
     Long-term Care/Death 
 
52 (72.2%) 
19 (26.8%) 
 
1108 (85.6%) 
187 (14.4%) 
χ2 = 7.98,  
df = 1, 
p = 0.009 
Length of Hospital Stay in 
days (±SD) 
12.3 (±17.2) 
Range (0-104) 
8.7 (±11.9) 
Range (1-117) 
t = 1.76, 
p = 0.08 
Month Test Requested 
     January 
     February 
     March 
     April 
 
25 (35.2%) 
15 (21.1%) 
26 (36.6%) 
5 (7.0%) 
 
399 (30.8%) 
416 (32.1%) 
466 (36.0%) 
14 (1.1%) 
 
Contingency 
coefficient = 
0.12, 
p ≤ 0.001 
 aApril data include only 6 days of observations.  AHP= Acute Hepatitis Panel; Chi-square = χ2; df = degrees of 
freedom; t-test = t. 
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Figure 6: Not Duplicated Group Shows Consistent Ordering Pattern Across Months; Duplicated 
Group Shows Greater Variability in Ordering Patterns Across Months (introduction of 
computerized alert was the likely factor contributing to this discrepancy). 
 
Note: April data includes only 6 days of observations.   
 
 For the logistic regression analysis, patient, test, and system factors (including the 
computerized alert status) found in the univariate analyses to be strongly associated with 
duplication (p-value < 0.20) (Table 6) were included in the analyses.  This was done in order to 
assess which factors (including the alert) had the strongest association with duplication and 
allowed for controlling for potential confounders to be able to truly assess the impact of the alert 
as an independent predictor of duplication. Duplication was defined by the AHP test being 
performed on the same patient more than one time within a 15 day time period of the initial 
result being present in the EMR.  
 Adjusted OR with 95% confidence intervals were calculated and presented in Figure 7.  
Results specifically for:  alert status, month of test, length of stay, disposition, mortality, test 
priority, and age are summed up in Table 7. Confidence intervals for all ORs contained the value 
of 1.0, except for the computerized alert status. The only independent predictor of duplication 
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was the presence of a computerized alert, regardless of severity of illness, time of year, length of 
stay, test priority, or patient’s age.  
 
 
Figure 7: Adjusted Odds Ratios for Patient, Test, and System Factors Relative to Duplication are 
Presented in the High-Low Graph with 95% CIs. 
 
Note.  Using combined data from both 2010 and 2011, potential predictors of AHP test duplication (dichotomized 
into patients with duplicated versus not duplicated tests) were assessed using logistic regression analysis. 
Duplication was defined by the AHP test being performed on the same patient more than one time (at least two tests 
on the same patent).  CI = confidence interval. 
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Table 7: Adjusted Odds Ratios with a 95% Confidence Interval for Patient, Test, and System 
Factors Relative to Duplication in 2010 and 2011 Pre- and Post-alert Study Periods Combined. 
Patient, Test, and System Factors Adjusted Odds Ratios 95% Confidence Interval 
Alert Status 0.32 0.18-0.55 
Month Test Requested 1.11 0.84-1.47 
Length of Stay 1.01 0.99-1.03 
Disposition 1.46 0.67-3.21 
Mortality 1.51 0.55-4.18 
Test Priority 1.30 0.71-2.39 
Age 1.00 0.99-1.02 
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CHAPTER 5: DISCUSSION 
 This chapter presents a discussion of the findings from this study.  Results are examined 
and compared to previous research in the area of unnecessary laboratory duplication and to the 
conceptual framework.  Implications for advanced nursing practice and recommendations for 
future research in the area of improving efficiency of care and reducing unnecessary duplication 
of laboratory testing are discussed.  Limitations of this study are identified and conclusions are 
presented.   
Discussions of Findings and Recommendations for Future Research 
This multi-phase study evaluated quality of care through the measurement of performance as it 
relates to efficiency by evaluating the total amount of duplicated laboratory tests in the hospital 
setting during a single admission and the cost associated with this process.  This study evaluated 
cost and resource use associated with unnecessary duplication of laboratory tests.  In addition, 
this study evaluated processes of care to determine if the implementation of a computerized alert 
would reduce unnecessary duplication of the AHP and reduce the associated costs of redundant 
AHP tests.   
  Study findings indicated that 4.6-8.7% of commonly ordered diagnostic tests appeared to 
be redundant.  These percentages are consistent with data from a defined group of commonly 
performed tests from one other study (Bates et al., 1998), but lower than percentages reported by 
other studies (Bates et al., 1999; Kwok & Jones, 2005; Nies, et al., 2010).  It is difficult to 
determine why the duplication proportions were higher in some of the other studies than those 
obtained here.  The differences may be related to the differences in the amount of overall tests 
performed in each test category in this hospital system, as compared to the amounts performed in 
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other studies (i.e. regional variations) (Bates et al., 1998; Bates et al., 1999; Kwok & Jones, 
2005; Nies et al., 2010).  Furthermore, these differences may be because the selected tests chosen 
for analysis in this study may be duplicated proportionally less than those tests selected for 
evaluations in other studies (Kwok & Jones, 2005; Nies et al., 2010) or because these tests were 
not evaluated in other studies (Bates et al., 1998; Bates et al, 1999).  Variations in ordering 
practices presented by other studies suggest that some of the test-ordering practices are 
suboptimal (Jackson, 2007).    
 This study found the overall yearly costs associated with duplication of six selected tests 
for inpatients, during one hospital stay, in one local tertiary care facility, were an estimated $419, 
218.  However, these cost estimations may be overestimated.  The costs were calculated using 
the actual 2011 charge for each test.  Laboratory charges are generally much higher than the 
costs associated with performing each test because they do not include the indirect costs (Bates, 
et al., 1998).  Despite this, and the fact the proportion of duplication of the six selected tests is 
small, it can easily be reasoned if this rate of duplication occurred on the wide range tests, the 
costs of duplication could affect overall hospital revenue in a single facility.  Multiply this 
number by multiple hospitals across the U. S. and it can easily be seen how such duplication 
encumbers the already burdened health care system and contributes needlessly to inflated 
healthcare costs in this country.    
 Of the six test categories (Table 1), the largest portions of redundant tests were TSH tests, 
resulting in an estimated yearly cost of $300,987 and B12/Folate test, resulting in an estimated 
yearly cost of $10,395.  It is difficult to place these findings in context since there are no 
published studies available describing unnecessary duplication and associated costs of 
duplication of these two tests.  However, discovering ways to reduce redundant TSH tests 
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represents a great target, because changes in the actual TSH level fall behind the serum TSH 
levels, and in most circumstances the level should be reevaluated no sooner than 4 weeks 
(Heuston, 2001).  Thus, finding ways to reduce the number of redundant TSH tests can be a way 
to improve system efficiency.  Similarly, targeting reduction in B12/Folate test duplication is 
important, as repeating this test in the hospital is rarely indicated. If the initial B12/Folate level is 
abnormal, supplementation of the deficient vitamin is clinically indicated (Smellie, et al., 2005).  
Although there are no definite published guidelines recommending supplementation duration and 
monitoring of B12/Folate levels, repeat levels are generally not necessary unless the cause of the 
deficiency (i.e. alcohol abuse, malnutrition) persists.  Furthermore, patients on supplementation 
should, by definition, not become vitamin deficient and there is no obvious cause for repeating 
these levels unless lack of compliance is suspected or anemia recurs (Smellie, et al., 2005).   
 Of the total number of requested tests in each test category, 15.2-22.9% were entered into 
the EMR to later be cancelled, contributing to the overall system workload.  The reasons for the 
cancellations varied and could stem from duplicate tests or patient discharges.  Although the 
reasons for the cancellations were not fully evaluated in this study, it may be one area in need of 
further research to determine if an overall reduction of test cancellations correlated with 
reductions in staff workload requirements and could reduce overall resource use in this area.   
 Similar to previous studies evaluating various computerized alerts (Bates et al., 1999; 
Neilson et al., 2004; Nies, et al., 2010), this study demonstrated a significant reduction in the 
total proportion of AHP tests after the initiation of the computerized alert intervention.  By 
February 2011, the trend of duplicated AHP tests dropped and remains consistently lower 
throughout April 2011, as compared to the same time in 2010.  This is likely related to the 
initiation of the computerized alert on January 5th, 2011.  Once the clinicians using this EMR 
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were familiar with the alert, the proportion of duplicated AHP dropped significantly.  This 
reduction equated to a significant reduction in associated costs of duplicate AHP tests after 
initiation of the computerized alert.  Although there were more inpatients within this tertiary care 
hospital system during the 2010 pre-alert study period, there were more AHP tests ordered 
during the 2011 post-alert study period.  Even so, the proportion of duplication of the AHP tests 
was significantly lower during the post-alert time period.  This further suggests the reduction in 
the proportion of duplicated AHP tests was impacted by the implementation of the computerized 
alert. 
 The patient, test, and system factors were similar in patients with duplicated AHP tests 
across the pre- and post-alert periods, with the exception of the month the duplicate test was 
requested.  This is likely due to initiation of the computerized alert, whereas the proportion of 
duplicated tests were proportionally lower from February through April 2011, post-alert 
initiation.  Thus, the alert worked overall, and not just on certain kinds of patients. These rates 
further indicate there is no alert fatigue in play.  Rates of duplicated tests remain low in the 
months following alert implementation.  This study attempted to identify patient, system, and test 
factors predictive for duplication of the AHP tests and found the only factor predictive for 
duplication of the AHP test was the computerized alert intervention, which reduced the number 
of redundant AHP tests. 
  After combining the two groups, those with and without duplicate AHP tests, results 
indicated the patient, test, and system factors were similar among those during the pre- alert 
study period in 2010 and the post-alert study period in 2011, with the exception of mortality and 
disposition (home/short-term rehab verses long-term care/death).  Disposition to home/ short-
term rehab was proportionally higher in those patients without duplicate AHP tests.  Conversely, 
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disposition to long-term care or death was proportionally higher patients who had a duplicated 
AHP test.  Mortality and disposition to long-term care/death were proportionally higher in 
patients who had a duplicate AHP test performed.  Mortality and disposition are considered 
surrogate markers for severity of illness.  Hence, this may indicate that patients who had 
redundant tests were generally sicker than those patients who did not.  However, further data and 
analysis would be needed to determine if illness severity explained this increased risk for having 
a duplicated AHP test.    
Limitations of Study 
 This study has several limitations.  First, study methods had limited rigor.  This study was 
conducted in one tertiary care organization with multiple facilities within the organization, which 
may limit the ability to generalize findings to other facilities or outpatient settings.  Also, the list 
of selected unnecessarily repeated laboratory tests is not all-inclusive.  Additionally, using a non-
randomized quasi-experimental design to examine the effect of a computerized alert on 
duplication of AHP tests may not be as powerful in establishing causal relationships between 
interventions and outcomes as a true experimental design.   
 The second limitation is related to using the actual 2011 hospital unit charge for each test 
for determining the costs associated with unnecessary duplication.  To accurately assess total 
costs of performing redundant laboratory tests, total costs and associated resources (i.e. staff, 
equipment, test tubes, etc.) would have to be included in the calculation.  Moreover, the actual 
test charge for each test is usually more than the overall costs to run the tests (Bates, et al., 1998), 
probably resulting in an overestimation of total costs associated with duplicate testing. 
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The third limitation is that the CPOE system was not mandatorily used in all facilities in 
this organization until October 2011.  Consequently, it is possible that some of the cancelled tests 
occurring in the pre-alert period were not recorded in the EMR.  However, the use or nonuse of 
the CPOE system had no impact on access to laboratory test result data.  The laboratory data 
prior to October 2010 was stored in a separate computer system within the laboratory and 
transferred into the EMR and available electronically during pre- and post-alert time periods.    
Implications for Future Research 
 Findings from this study argue for research to determine if the reduction of duplicated 
AHP tests following the implementation of the computerized alert are sustained over time or if 
the phenomena of alert fatigue would prohibit sustained reductions.  This finding would support 
research regarding the utilization of a computerized alert with other laboratory tests, with 
evidence-based, test-specific time intervals, demonstrating reductions in the total amount and 
subsequent costs of unnecessarily duplicated tests.  For example, research is needed to determine 
if the use of a computerized alert, set with a 4-week test specific time limit, would reduce the 
total number of duplicated TSH tests and/or affect treatment plans or patient outcomes.  
Furthermore, research is needed to determine if the implementation of a B12/Folate 
computerized alert would reduce its unnecessary duplication.  The findings from this study 
regarding the AHP computerized alert argue for the success of a TSH or B12/Folate 
computerized alert.  Research is also needed to evaluate the effect of the alerts on the diagnostic 
reasoning process.  This research could help to develop more intelligent computer decisions 
support.   
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 Lessons learned during the data collection phase of this study have implications for 
research planning and procedures.  For example, the data obtained from the IT report writer was 
initially found to have a discrepancy in the amount of duplication of the ANA tests, leading to a 
recollection of the data by the primary investigator.  The original data file reported the ANA was 
duplicated even if it wasn’t by “seeing the duplicate” as the pattern result of the ANA, if the 
ANA test was positive (i.e. positive ANA plus pattern result was read as two test instead of one).  
The IT department report writer, during the screen for all ANA tests, requested ANA (ab) and 
ANA (abs).  The ANA (abs) portion in the system referred to the pattern and was not a duplicate 
ANA test. This is an example of a lesson learned during this study and an important 
consideration for researchers performing electronic chart reviews using historical data. It 
demonstrates the need for careful collaboration with the IT department report writer to assure 
that the data provided is clearly demonstrating the data being asked for and the need for data 
verification prior to analyses. 
Implications for Advanced Practice Nurses 
 The results of this study suggest the proportion of duplication of the six selected tests and 
the associated costs of such duplication is a significant problem.  This has clear implications for 
APNs because they are charged with improving population health, including directing resources 
into appropriate areas and reducing waste in other areas.  Moreover, the results of this study 
suggest particular strategies the APN can employ to reduce costs associated with needless 
duplication of diagnostic tests.  Strategies these APNs could employ include, collaborating with 
the IT team to implement computerized alerts for the TSH and B12/Folate tests, with evidence-
based test-specific time periods, and monitoring and evaluating their healthcare system’s 
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laboratory utilization.  APNs could investigate test-ordering behaviors in their own systems to 
determine if the implementation of computerized alerts on certain laboratory or radiographic 
studies would reduce health care costs in their system.  
 In this study, substantive and needless costs associated with unnecessary diagnostic test 
duplication were observed.   The findings of this study suggest a reduction in the duplication of 
the AHP test using the computerized alert intervention.  Healthcare policy necessitates 
demonstration of “meaningful use” of the EMR for funding of the EMR.   APNs could replicate 
this study in their facilities to determine what increased efficiencies in care could be possible 
with elimination of duplicate testing and to demonstrate meaningful use of their own EMR. 
Summary 
 The healthcare delivery system has a primary objective to maximize health, reduce 
illness, and improve efficiency of healthcare resources (NQF, 2009).  Redundant testing reduces 
the quality of our healthcare system as it uses more resources than necessary (Ransom et al., 
2008).  This study found small redundancies in six commonly run laboratory tests.  However, the 
total costs associated with these redundancies affects hospital revenue and reduces overall 
efficiency of patient care.  The implementation of the AHP computerized alert was shown to 
reduce the number of redundant AHP tests and subsequent associated costs in one tertiary care 
hospital system.  This chapter discussed the findings of this study, its limitations, and 
implications for future research and for APNs. 
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APPENDIX A: UNIVERSITY OF CENTRAL FLORIDA INSTITUTIONAL REVIEW 
BOARD APPROVAL  
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APPENDIX B: FACILITY INSTITUTIONAL REVIEW BOARD APPROVALS 
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APPENDIX C: DEMOGRAPHIC CHARACTERISTICS FOR PATIENTS WITH APH 
TESTS IN FIRST QUARTER 2010 COMPARED TO Q2, Q3, AND Q4 2010 
(COMBINED) TO ASSESS IF SAMPLE REPRESENTS REST OF YEAR 
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 Patients in the 1st 
Quarter of 2010 
N=657 
 
Patients in 2nd, 3rd, 
and 4th Quarters of 
2010 
N=1857 
Statistic and p 
Value 
Age in years (±SD) 54 (±18) 
Range (24-93) 
53 (±18) 
Range (23-89) 
t = -1.25,  
p = 0.21 
 
Gender (% female) 329 (50.1%) 895 (48.2%) χ2 = 0.69,  
df= 1,  
p = 0.41 
 
Race  
     Asian 
     Black 
     Caucasian 
     East Indian 
     Hispanic 
     Other 
 
 
22 (3.3%) 
158 (24.0%) 
338 (51.4%) 
10 (1.5%) 
124 (18.9%) 
5 (0.8%) 
 
44 (2.4%) 
491 (26.4%) 
930 (50.1%) 
18 (1.0%) 
363 (19.5%) 
 
 
Contingency 
coefficient = 
0.04, 
p = 0.46 
Order Status (%) 
     Routine 
     Stat/Timed 
 
541 (82.3%) 
116 (17.7%) 
 
1546 (83.3%) 
311 (16.7%) 
χ2 = 0.28;    
  df = 1;   
p = 0.59 
 
Mortality 32 (4.9%) 76 (4.1%)  χ2=0.71;  
df = 1;  
p = 0.43 
 
Length of Hospital 
Stay in days (±SD) 
8.7 (±12.2) 
Range (1-117) 
9.4 (±12.3) 
Range (1-208) 
t = 1.13,  
p = 0.26 
 
 
Note. N = number; Chi-square = χ2; df = degrees of freedom; t-test = t. 
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